FDA — authorised 17 April 1957
- Application: NDA010753
- Marketing authorisation holder: WYETH AYERST
- Local brand name: ESTRADURIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Estradurin in United States
FDA authorised Estradurin on 17 April 1957
Marketing authorisations
FDA
- Status: approved
Estradurin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is Estradurin approved in United States?
Yes. FDA authorised it on 17 April 1957; FDA has authorised it.
Who is the marketing authorisation holder for Estradurin in United States?
WYETH AYERST holds the US marketing authorisation.